BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38376003)

  • 21. [Active fractions of Camellia nitidissima inhibit non-small cell lung cancer via suppressing epidermal growth factor receptor].
    Wang ZL; Guo YJ; Zhu YY; Chen L; Wu T; Liu DH; Huang BS; DU HZ
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5362-5371. PubMed ID: 34738440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular mechanism of erlotinib resistance in epidermal growth factor receptor mutant non-small cell lung cancer cell line H1650].
    Han R; Wang X; Zhong D; Zhao J; Chen Z; Sun L; Wang J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):689-93. PubMed ID: 23249714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques].
    Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling.
    Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H
    EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY; Lam SK; Mak JC; Zheng CY; Ho JC
    Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
    Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psorachromene induces apoptosis and suppresses tumor growth in NSCLC cells harboring EGFR L858R/T790M/C797S.
    Wang TH; Leu YL; Chen CC; Li HJ; Yang SC; Huang KY; Chen CY
    Phytother Res; 2022 May; 36(5):2116-2126. PubMed ID: 35229911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology.
    Tan YR; Lu Y
    Mol Divers; 2023 Jun; 27(3):1437-1457. PubMed ID: 35933455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of EGFR/STAT3 activity by lupeol contributes to the induction of the apoptosis of human non‑small cell lung cancer cells.
    Min TR; Park HJ; Ha KT; Chi GY; Choi YH; Park SH
    Int J Oncol; 2019 Jul; 55(1):320-330. PubMed ID: 31115519
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
    Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
    BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
    Amujuri D; Siva B; Poornima B; Sirisha K; Sarma AVS; Lakshma Nayak V; Tiwari AK; Purushotham U; Suresh Babu K
    Eur J Med Chem; 2018 Apr; 149():182-192. PubMed ID: 29501940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
    Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
    Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
    Cragg MS; Kuroda J; Puthalakath H; Huang DC; Strasser A
    PLoS Med; 2007 Oct; 4(10):1681-89; discussion 1690. PubMed ID: 17973573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.
    Zhang FQ; Yang WT; Duan SZ; Xia YC; Zhu RY; Chen YB
    Oncotarget; 2015 Jun; 6(16):14329-43. PubMed ID: 25869210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual inhibition of EGFR and MET by Echinatin retards cell growth and induces apoptosis of lung cancer cells sensitive or resistant to gefitinib.
    Oh HN; Lee MH; Kim E; Kwak AW; Seo JH; Yoon G; Cho SS; Choi JS; Lee SM; Seo KS; Chae JI; Shim JH
    Phytother Res; 2020 Feb; 34(2):388-400. PubMed ID: 31698509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.
    Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Firdaus JU; Rahman S; Jha M; Sheikh AA
    Anticancer Agents Med Chem; 2021; 21(1):42-60. PubMed ID: 32718297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET.
    Oh HN; Lee MH; Kim E; Kwak AW; Yoon G; Cho SS; Liu K; Chae JI; Shim JH
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32070026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-circulating doxorubicin and schizandrin A liposome with drug-resistant liver cancer activity: preparation, characterization, and pharmacokinetic.
    Xu SY; Su H; Zhu XY; Li XY; Li J; Chen X; Wang Q; Hao RY; Yan XY
    J Liposome Res; 2022 Jun; 32(2):107-118. PubMed ID: 33555226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.